InflaRx (IFRX) Operating Leases (2017 - 2025)

InflaRx has disclosed Operating Leases across 9 years of filings, most recently posting $1.0 million for Q4 2025.

• Operating Leases for Q4 2025 came in at $1.0 million, up 21.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.0 million (up 21.49% YoY), and the FY2025 annual result was $1.0 million, up 21.49% from the prior year.
• Operating Leases came in at $1.0 million for Q4 2025 at InflaRx, up from $860311.2 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1362.6 billion in Q3 2021 to a low of -$244.8 million in Q4 2021.
• The 5-year median for Operating Leases is $1.1 million (2023), against an average of $227.1 billion.
• Peak annual rise in Operating Leases reached 947882.36% in 2021, while the deepest fall reached 193.2% in 2021.
• InflaRx's Operating Leases stood at -$244.8 million in 2021, then surged by 100.57% to $1.4 million in 2022, then dropped by 12.94% to $1.2 million in 2023, then decreased by 28.61% to $860311.2 in 2024, then grew by 21.49% to $1.0 million in 2025.
• The last three Operating Leases figures came in at $1.0 million (Q4 2025), $860311.2 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.